|
CEP55 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 4.351800E-01 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
3.129800E-01 |
| Normal-vs-Stage2 |
3.191200E-01 |
| Normal-vs-Stage3 |
5.067800E-01 |
| Normal-vs-Stage4 |
2.552800E-01 |
| Stage1-vs-Stage2 |
1.247380E-04 |
| Stage1-vs-Stage3 |
6.117200E-01 |
| Stage1-vs-Stage4 |
6.624600E-01 |
| Stage2-vs-Stage3 |
7.535800E-03 |
| Stage2-vs-Stage4 |
4.756700E-03 |
| Stage3-vs-Stage4 |
4.598600E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
2.563400E-01 |
| Normal-vs-AfricanAmerican |
9.691600E-01 |
| Normal-vs-Asian |
5.740600E-01 |
| Caucasian-vs-AfricanAmerican |
3.214600E-01 |
| Caucasian-vs-Asian |
4.210400E-01 |
| AfricanAmerican-vs-Asian |
5.701000E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
4.882800E-01 |
| Normal-vs-Female |
4.309800E-01 |
| Male-vs-Female |
9.123800E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.312830E-01 |
| Normal-vs-Age(41-60Yrs) |
8.015800E-01 |
| Normal-vs-Age(61-80Yrs) |
7.020400E-01 |
| Normal-vs-Age(81-100Yrs) |
3.658200E-02 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
3.220300E-04 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
9.322300E-02 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
4.665700E-02 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
2.654800E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
6.191500E-02 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
9.715800E-02 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
4.090200E-01 |
| Classical-VS-Follicular |
9.43569999911631E-08 |
| Classical-VS-Other |
1.357760E-01 |
| Classical-VS-Normal |
2.005000E-01 |
| Tall-VS-Follicular |
2.458000E-03 |
| Tall-VS-Other |
8.606100E-02 |
| Tall-VS-Normal |
1.504370E-01 |
| Follicular-VS-Other |
4.788200E-01 |
| Follicular-VS-Normal |
2.257600E-01 |
| Other-VS-Normal |
8.059000E-01 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
8.576800E-01 |
| Normal-vs-N1 |
4.631600E-01 |
| N0-vs-N1 |
3.157800E-01 |
|
|
